Sort
23,748 grants matching “melanoma”
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose
$299,009Jonathan H Schatz · University Of Miami School Of Medicine · R01 · FY2017 · CA
GRNs Guiding Cranial Versus Trunk Neural Crest Formation
$298,943Marianne Bronner · California Institute Of Technology · P01 · FY2016 · HD
Role of CXCR3 for CD8+ T cells in cancer immunotherapy
$298,935David W. Mullins · Dartmouth College · R01 · FY2013 · CA
Cancer cell telomere dynamics and responses to perturbations
$298,913Elizabeth H Blackburn · University Of California, San Francisco · R01 · FY2011 · CA
Multiplexed Bioassay for Checkpoint Inhibitor Autoimmunity
$298,911Mark J. Mamula · L2 Diagnostics, Llc · R41 · FY2020 · AI
Bifunctional Protein-Polymer Bioconjugates for Localized Melanoma Immunotherapy
$298,864Wesley Michael Jackson · Valitor, Inc. · R43 · FY2018 · CA
ESTABLISHING THE ROLE OF DEPLOYMENTS IN MELANOMA IN THE MILITARY
$298,862The University Of Iowa · · FY2021 · Defense Health Agency
IDENTIFICATION AND CONTROL OF CANCER RISK
$298,808Harvard University (Sch Of Public Hlth) · R01 · FY2000 · CA
Store-operated calcium entry in tumor invasion and metastasis
$298,807Shengyu Yang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · CA
P53 inactivation on MDSC development and tumor progression
$298,800Yan Cui · Lsu Health Sciences Center · R01 · FY2013 · CA
Regulation of PTEN Activity in Cancer Cells
$298,795University Of Arizona · R01 · FY2002 · CA
Arf6 inhibitors for the treatment of uveal melanoma
$298,731Alan L Mueller · Navigen, Inc. · R43 · FY2015 · CA
Development of a novel Virus-Like Particle vaccine-based cancer immunotherapy targeting PD-L1.
$298,729Wataru Akahata · Vlp Therapeutics, Llc · R43 · FY2017 · CA
Fusogenic Membrane Glycoproteins for Cancer Gene Therapy
$298,688Mayo Clinic · R01 · FY2005 · CA
Fusogenic Membrane Glycoproteins for Cancer Gene Therapy
$298,688Mayo Clinic · R01 · FY2004 · CA
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
$298,619Mary J.c. Hendrix · Lurie Children'S Hospital Of Chicago · R01 · FY2007 · CA
Project 4: Immunovirotherapy
$298,617Richard G Vile · Mayo Clinic Rochester · P50 · FY2021 · CA
PD-1 Abrogation and Immunity in Melanoma
$298,576Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
Understanding resistance in the HER2-HER3 tumor drive
$298,554Mark M Moasser · University Of California, San Francisco · R01 · FY2015 · CA
Understanding resistance in the HER2-HER3 tumor drive
$298,554Mark M Moasser · University Of California, San Francisco · R01 · FY2017 · CA
Understanding resistance in the HER2-HER3 tumor drive
$298,554Mark M Moasser · University Of California, San Francisco · R01 · FY2016 · CA
Role of a novel Notch1 target gene in skin carcinogenesis
$298,542Anna Mandinova · Massachusetts General Hospital · R01 · FY2014 · CA
Production of Image-Guided Metastatic Melanoma Therapy Radiopharmaceuticals
$298,530Frances L Johnson · Viewpoint Molecular Targeting, Inc. · R43 · FY2016 · CA
Developement of an alphavirus vaccine for melanoma
$298,527Gerald P Donovan · Progenics Pharmaceuticals, Inc. · R43 · FY2007 · CA
GCDH Addiction in Melanoma
$298,503Ze'ev A Ronai · Cedars-Sinai Medical Center · R01 · FY2024 · CA